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Intracellular targetA tryptophan (Trp)-rich region in the wheat endosperm protein, puroindoline A, was previously shown to pos-
sess potent antimicrobial activity against Gram-positive and Gram-negative bacteria and this was attributed to
the peptide inducing membrane instability. In the present work, the antimicrobial activity of the corresponding
Trp-rich region in the puroindoline B isoform was examined and its antimicrobial activity was characterized.
Unexpectedly, the puroindoline B Trp-rich peptide (PuroB) was relatively inactive compared to the related
puroindoline A peptide (PuroA), despite strong sequence similarity. Using the sequence of PuroA as a template,
a series of PuroB variants were synthesized and the antimicrobial activity was restored. Interestingly, all of these
PuroB peptides preferentially interacted with negatively charged phospholipids, but unlike PuroA, they did not
disrupt the integrity of lipid bilayers. This suggests that the primary mode of action of the PuroB peptides
involves an antimicrobial target other than the bacterial membrane. Further tests revealed that all of the
puroindoline derived peptides bind deoxyribonucleic acid (DNA) and block macromolecular synthesis in vivo.
Based on these results, it appears that the interaction between puroindoline derived peptides and membranes
is only an initial step in the mode of action and that binding to intracellular targets, such as DNA and ribonucleic
acid (RNA), contributes signiﬁcantly to their antimicrobial mode of action.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
The problem of antibiotic resistance has spurred continued interest
in antimicrobial peptide research. Naturally occurring antimicrobial
peptides continue to be discovered in a variety of organisms and
de novo synthetic peptides have also been generated through combina-
torial chemistry, for example [1]. A different approach to identifying
antimicrobial peptides involves excising peptide fragments from larger
proteins to generate novel sequences. This strategy has been used to
identify a number of antimicrobial sequences including lactoferricin
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l rights reserved.the iron binding protein, lactoferrin. Other examples of antimicrobial
peptides isolated from larger proteins include peptides derived from
lysozyme [5] and histones [6,7]. In this study, we focus on a series of
antimicrobial peptides based on sequences from wheat puroindolines.
Puroindolines are highly basic, Trp- and Cys-rich proteins found
in wheat (Triticum aestivum) endosperm [8,9]. In fact, the name
puroindoline is derived from puros, the Greek word for wheat, and
the indole ring found in the side chain of Trp residues [10]. The
pinA and pinB genes are both located in the hardness locus of the
wheat genome and they encode the puroindoline A and puroindoline
B proteins respectively [11,12]. These two puroindoline proteins
share 55% sequence homology with each other and are unique be-
cause of the presence of 5 disulﬁde bonds, a large number of basic
residues and a tryptophan-rich region [9]. In addition to controlling
the hardness of the wheat kernels, puroindolines also exhibit antimi-
crobial and antifungal properties [13–16]. Part of this antimicrobial
activity is thought to be related to the ability of full length puroindoline
to induce pores in lipid bilayers [10,17], a feature which is attributed to
the Trp-rich loop in the native protein. This is of particular interest be-
cause this region resembles other Trp-rich cathelicidin antimicrobial
peptides such as bovine indolicidin [18] and porcine tritrpticin [19,20].
In an effort to understand the antimicrobial and lipid binding properties
of the puroindolines, we sought to examine peptide fragments based on
the Trp-rich loops from puroindoline A and B.
Our group previously studied a 13-residue peptide corresponding
to the Trp-rich region in puroindoline A (FPVTWKWWKWWKG-NH2).
Table 1
Sequences and net charges of the puroindoline peptides.
Peptide Sequence Net charge
PuroB1 FPVTWPTKWWKG-NH2 +3
PuroB2 FPVTWRTKWWKG-NH2 +4
PuroB3 FRVTWRTKWWKG-NH2 +5
PuroB4 FAVTWATKWWKG-NH2 +3
PuroB5 FKVTWKTKWWKG-NH2 +5
PuroA FPVTWKWWKWWKG-NH2 +4
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positive and Gram-negative bacteria and we concluded that this
13-mer (PuroA) constitutes the antimicrobial active center of
puroindoline A [21]. The NMR structure of PuroA in the presence of
SDS micelles adopts a partially helical amphipathic structure. In
addition, PuroA preferentially interacts with negatively charged
membranes and causes calcein leakage from negatively charged
liposomes [21]. Based on these observations, it was concluded that
PuroA employs a lytic mechanism to exert its antimicrobial effect.
The corresponding Trp-rich region in puroindoline B is a 12-mer
(FPVTWPTKWWKG-NH2) with remarkable sequence similarity to
PuroA. However, when tested for antimicrobial activity, this 12-mer
(PuroB1) was inactive compared to PuroA (see below). In this work,
a series of peptides based on the PuroB1 sequence were synthesized
in an attempt to increase the antimicrobial potency of this peptide.
Three of these PuroB derivatives demonstrated antimicrobial activity
against Escherichia coli and Staphylococcus aureus at similar concen-
trations to those seen for PuroA. Interestingly, biophysical character-
ization of the interactions between the PuroB peptides and lipids
suggests that the principal mechanism of action does not involve
the disruption of the bacterial membrane. Instead, our results suggest
that the PuroB peptides cross the bacterial cytoplasmic membrane
and bind to nucleic acids within the cell, blocking macromolecular
synthesis of DNA, RNA and proteins. In addition, continued investiga-
tions of the PuroA peptide revealed that the membrane destabilizing
effects of this peptide contribute to a more complex mode of action
that also includes an intracellular mode of action.
2. Materials and methods
2.1. Chemicals and reagents
All the phospholipids (ePC, ePG, DPPG, DPPC, DiPoPE and PLE)
as well as DPC were obtained from Avanti Polar Lipids (Alabaster, AL)
as stock solutions dissolved in chloroform. SDS was obtained from
EMD Chemicals Inc. (Gibbstown, NJ). 3,3′-Dipropylthiadicarbocyanine
iodide (diSC3-5) was purchased from AnaSpec Inc. (Fremont, CA). Deu-
terated d25-SDS was purchased from Cambridge Isotopes Laboratories
(Andover, MA). [methyl-3H]-thymidine (6.7 Ci/mmol) and [5-3H]-
uridine (25.5 Ci/mmol) were obtained from Perkin Elmer (Waltham,
MA) while [ring-2,5-3H]L-histidine (47.7 Ci/mmol) was purchased
from Moravek Biochemicals and Radiochemicals (Brea, CA). All
other reagents and chemicals were obtained from Sigma-Aldrich
(St. Louis, MO).
2.2. Peptide sources
The puroindoline derived peptides were synthesized by AnaSpec
(Fremont, CA) or at the University of Western Ontario peptide syn-
thesis facility (London, Ont. Canada). All peptides were obtained at
a purity of >95% as determined by HPLC and were used without fur-
ther puriﬁcation. The identity of each peptide was conﬁrmed by mass
spectrometry. All of the peptides were amidated at their C-terminus
to remove the negative charge of the C-terminal carboxyl group.
The sequences and net charges of the puroindoline peptides are
shown in Table 1. Melittin (GIGAVLKVLTTGLPALISWIKRKRQQ-NH2),
puriﬁed from honey bee venom, was purchased from Sigma-Aldrich.
2.3. Peptide concentration determination
Peptide concentrationswere determined based on the absorbance at
280 nm of a diluted peptide stock solution and the concentration was
calculated according to Beer's law using theoretical extinction coefﬁ-
cients of 27500 M−1 cm−1, 16500 M−1 cm−1 and 5500 M−1 cm−1
for PuroA, all the PuroB peptides and melittin respectively. Theoreticalextinction coefﬁcients were generated with the ProtParam tool on the
ExPASY proteomics server [22].
2.4. Antimicrobial and hemolytic activity
The antimicrobial and hemolytic activities of the PuroB peptides
were determined using the same procedure described for PuroA
[21]. Brieﬂy, E. coli ATCC 25922 and S. aureus ATCC 25923 were
grown to the exponential phase in 2% Bacto Peptone water (Difco
1807-17-4). The cell suspensions were diluted to 2 × 106 cfu/ml
(3.8 × 108 cfu/ml = 1U of A600) in 2% Bacto Peptone Water and then
added to the wells of 96-well polystyrene plates. Peptides were added
to wells at concentrations ranging from 300 to 1.0 μg/ml and the plates
were incubated overnight at 37 °C. The change in turbidity at 540 nm
was measured and the MIC was deﬁned as the lowest concentration
of peptide that inhibited growth. All peptides were tested in triplicate.
To determine the hemolytic activity, human erythrocytes were
isolated from heparinized human blood by centrifugation followed
by threewashes in phosphate-buffered saline (5 mMphosphate buffer,
150 mMNaCl, pH 7.4). Cell suspensions containing ~107 cells/ml were
incubatedwith peptide for 30 min at 37 °Cwith gentlemixing. The cells
were centrifuged and the absorbance at 540 nm was measured. Zero
percent hemolysis was measured by adding phosphate buffer to the
erythrocyte suspension while 100% hemolysis was achieved by adding
1% Triton X-100 to the erythrocytes.
2.5. Tryptophan emission ﬂuorescence
Spectra were acquired on a Varian Cary Eclipse Fluorimeter (Varian
Inc., Palo Alto, CA) equipped with a temperature control device set to
25 °C. Tryptophan emission spectra were collected between 300 and
450 nm using an excitation wavelength of 295 nm and excitation and
emission slit widths of 10 nm. All samples contained 1 μM peptide
in buffer (10 mM Tris, 150 mM NaCl. 1 mM EDTA, pH 7.4). Samples
containing SDS and DPC were prepared to a ﬁnal detergent concentra-
tion of 25 mM. Samples containing large unilamellar vesicles (LUVs,
see calcein leakage section for details on LUV preparation) were made
to a ﬁnal lipid concentration of 30 μM.
Lipid binding was measured by titrating aliquots of E. coli polar
lipid extract LUVs into 0.5 μM peptide solutions in buffer. After each
addition of lipid, an emission spectrum was recorded between 300
and 400 nm using an excitation wavelength of 280 nm. Blank spectra
were recorded for each addition of LUV into buffer and subtracted in
the ﬁnal analysis. The wavelength maxima (λmax) were determined
by taking the slope of the emission spectra and using the wavelength
where this value was closest to zero. The λmax values were plotted as
a function of lipid concentration and the dissociation constants (Kd)
were calculated in CaLigator [23] using a least-squares ﬁt algorithm
and a one-site binding model. The CaLigator software is typically
used to determine calcium binding constants to proteins but it can
also be used to evaluate the binding of any two interacting partners.
2.6. Acrylamide quenching of emission ﬂuorescence
Stern–Volmer constants (Ksv) [24] were calculated as described
previously [25,26]. Brieﬂy, 5 μl aliquots of a 4 M acrylamide solution
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described above. After each addition of acrylamide, a tryptophan
emission spectrum was acquired. The Ksv for each combination of
peptide and lipid was calculated using the following formula:
Fo=F ¼ 1þ Ksv Q½ 
where Fo is the maximum ﬂuorescence emission intensity of the
peptide in buffer and F is the intensity following the addition of the
soluble quencher, Q.
2.7. Differential scanning calorimetry
DSC experiments with DPPG and DPPC phospholipids were
performed according to a modiﬁed protocol originally described by
Prenner et al. [27]. DiPoPE experiments were carried out according
to Powers et al. [28]. Brieﬂy, 0.5 mg of DPPG, 0.5 mg of DPPC lipid
or 5 mg of DiPoPE from stock chloroform solutions was added to
small glass vials and lipid ﬁlms were generated as described above.
To prepare the DSC sample, the lipid ﬁlm and buffer (20 mM sodium
phosphate with 130 mMNaCl, pH 7.4 for DPPG and DPPC samples or
10 mM Tris, 100 mM NaCl, 2 mM EDTA pH 7.4 for DiPoPE samples)
were heated for 15 min at 55 °C and then warm buffer was added
to the lipid and vortexed vigorously. The DiPoPE samples were also
sonicated for ~3 h to resuspend the lipid. Following lipid resuspension,
peptide was added from a stock solution to give a ﬁnal lipid:pepide
molar ratio of 10:1. Samples of pure lipidwere also prepared for compar-
ison. The ﬁnal lipid concentration in the DPPC and DPPG samples was
0.5 mg/ml while the DiPoPE samples were all prepared to a ﬁnal lipid
concentration of 5 mg/ml. All DSC experiments were carried out on a
Microcal high-sensitivity VP-DSC instrument (Microcal, Northampton,
MA). For the DPPG and DPPC samples, an initial buffer–buffer scan be-
tween 20 and 60 °C was performed then the degassed lipid and peptide
mixture was loaded into the sample cell as it cooled. Four heating scans
were performed between 20 and 60 °C at a scan rate of 10 °C/h. For the
DiPoPE samples, ﬁve heating scans were recorded between 10 and 60 °C
at a scan rate of 60 °C. In all cases, the ﬁnal heating scan was analyzed in
the Microcal Origin software package (version 7.0).
2.8. Circular dichroism spectroscopy
CD spectra were acquired at room temperature on a Jasco-J810
Spectropolarimeter (Jasco, Easton, MD) using a 1 mm pathlength cu-
vette. Each sample contained 50 μM peptide in buffer (25 mM sodium
phosphate buffer, pH 7) or in a buffered solution with 30 mM SDS.
A blank spectrum, lacking peptide, was also recorded and subtracted
in the ﬁnal analysis. Far-UV CD spectra were collected between
260 nm and 190 nm using a 0.5 nm step size and a scanning speed
of 100 nm/min. The bandwidth was set to 1 nm and the response
was set to 0.5 s. Ten spectra were accumulated and averaged to gen-
erate the ﬁnal spectra. The mean residue ellipticity was calculated
according to Wallace and Janes [29].
2.9. NMR structure determination
NMR structure determination was performed on unlabelled peptide
samples using two-dimensional NMR spectroscopy. Samples were pre-
pared by dissolving the lyophilized peptide in a 90:10 mixture of H2O:
D2O to a ﬁnal concentration of 1–2 mM. DSS was added as an internal
standard to a ﬁnal concentration of 20 μM and the pH was adjusted to
between 3.5 and 4.5 using HCl or NaOH. Following data collection on
the aqueous sample, deuterated SDS (Cambridge Isotopes Laboratories,
Inc. Andover, MA) was added to a ﬁnal concentration of 200 mM and
the pH was readjusted to fall within the same range.
All NMR spectra were recorded on a Bruker Avance 700 MHz spec-
trometer at 298°K. Two-dimensional NOESY spectra were recordedfor the aqueous peptide samples using a mixing time of 500 ms.
NOESY, TOCSY and COSY spectra were acquired for the detergent
containing samples. Mixing times of 100 ms and 120 ms were used
in these NOESY and TOCSY experiments respectively. Data were col-
lected with 4096 × 600 data points in the F2 and F1 dimensions at
a sweep width of 8992.806. Water suppression was achieved using
excitation sculpting [30]. Processing of the spectra was performed
using the NMR pipe software [31]. The 2-D data were zero ﬁlled
once in each dimension and Fourier transformed with a shifted sine-
bell function. Visualization and analysis of all the spectrawas performed
in NMRView [32].
Starting structures for the PuroB peptides were generated with
CNS [33] and the micelle bound peptide structures were calculated
using the simulated annealing protocol in ARIA 1.2 [34]. Peptide
structures were calculated based on NOE crosspeaks assigned from
the 2D 1H-NOESY spectra. The backbone phi and psi angles of non-
Gly and Pro residues were also restrained to fall within allowed re-
gions of the Ramachandran plot [35]. Nine iterations of simulated
annealing were performed with 20 structures calculated in the ﬁrst
7 iterations followed by 40 and 100 structures in the ﬁnal two itera-
tions respectively. The 20 lowest energy structures from the ﬁnal iter-
ation were used in the ﬁnal analysis. The 3-D peptide structures were
visualized in MOLMOL [36] and the quality of the structures was eval-
uated with Procheck [37].
2.10. Calcein leakage from LUVs
The release of calcein from LUVs of varying composition was
measured for all ﬁve PuroB derivatives using the procedure described
by Nguyen et al. [38]. Melittin, a known lytic peptide, was used as a
positive leakage control. Lipid ﬁlms were prepared by placing 1 mg
of stock lipid solution, dissolved in chloroform, in a glass vial. The
chloroform was evaporated in a stream of nitrogen gas and the
resulting lipid ﬁlm was placed under vacuum for ~2 h to remove
any trace organic solvent. Lipid ﬁlms were kept at −20 °C until
ready for use. To generate calcein encapsulated LUVs, lipid ﬁlms were
resuspended in buffer (10 mM Tris, 150 mM NaCl, 1 mM EDTA,
pH 7.4) containing 70 mM calcein. Calcein free LUVs, used in the
tryptophan ﬂuorescence experiments, were generated in the same
way using calcein free buffer. The lipid suspension was subjected
to 5 cycles of liquid nitrogen freezing and warm water thawing
followed by 15 passes through two 0.1 μM polycarbonate ﬁlters
using a mini-extruder apparatus (Avanti Polar Lipids, Alabaster).
The calcein encapsulated LUVs were separated from free calcein as
the ﬁrst strong yellow fraction to elute from a Sephadex G50 gel
ﬁltration column. The lipid concentration in each LUV preparation
was determined by measuring the phosphate concentration according
to the procedure developed by Ames [39]. The lipid composition of
the LUVs tested for calcein leakge was: DPPC, DPPC:DPPG, ePC, ePC:
ePG and E. coli polar lipid extract (PLE).
2.11. E. coli cytoplasmic membrane depolarization
Membrane depolarization of E. coli was measured using a modi-
ﬁed protocol originally described by Chongsiriwatana and Barron
[40]. The antibiotic-susceptible DC2 E. coli strain [41] was obtained
from the CGSC (Yale University, New Haven, CT) and was used in
these experiments because it possesses a defective outer membrane,
giving the peptide access to the bacterial cytoplasmic membrane
without the need for EDTA [42]. Bacterial cultures in LB broth were
grown at 37 °C to an OD600 of ~0.4 and then 5 ml of culture was
harvested at ~3200 ×g for 10 min. The cell pellet was resuspended
in 5 ml of respiration buffer (5 mM HEPES, 20 mM glucose, pH 7.4)
and then 10–20 ml of an OD600 of 0.05 DC2 cell suspension was pre-
pared and kept at 4 °C until the addition of diSC3-5. 1 h prior to mea-
suring the membrane depolarization, diSC3-5 was added to 1.5 ml of
Table 2
Antimicrobial and hemolytic activity of puroindoline derived peptides.
Peptide MIC
E. coli (μM)
MIC
S. aureus (μM)
Hemolytic concentration (μM) EC50
PuroB1 >125 >125 >300
PuroB2 15.5 >3.1 >300
PuroB3 6.0 b3.0 >600
PuroB4 >125 100 >300
PuroB5 3.1–6.2 6.2–9.3 >600
PuroAa 5.3 20 >500
a Previously published by Jing et al. [21].
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was equilibrated at room temperature for 1 h, with occasional mixing.
1 ml was transferred to a quartz cuvette and the ﬂuorescence emission
intensity at 670 nm (excitation 622 nm) was measured for 1 min.
The peptide was then added to a ﬁnal concentration of 6 μM and
the ﬂuorescence was measured for 5 min. Finally, 10 μl of a 10%
Triton-X100 solution was added and the ﬂuorescence intensity was
monitored for an additional 9 min. As a positive control, the membrane
depolarization induced by 20 μM melittin was measured as indicated
by Chongsiriwatana and Barron [40].
2.12. DNA binding assay
To examine peptide binding to DNA, an agarose gel-retardation
assay was performed similar to that described by Park et al. [43].
Unmodiﬁed pET-19b plasmid was puriﬁed from an overnight 5 ml
culture of DH5α cells harboring the vector using the Qiagen Plasmid
Puriﬁcation Kit (Qiagen Inc.Valencia, CA). The puriﬁed plasmid con-
centration was determined using a NanoDrop instrument (NanoDrop
Products, Wilmington, DE). 100 ng of the plasmid was incubated at
room temperature with increasing amounts of peptide in 20 μl of
binding buffer (5% glycerol, 10 mM Tris–HCl at pH 8.0, 1 mM EDTA,
1 mM DTT, 20 mM KCl and 50 ug/ml BSA). After 1 h of incubation,
4 μl native loading buffer (10% Ficoll 400, 10 mM Tris–HCl, 50 mM
EDTA, 0.25% bromophenol blue at pH 7.5) was added to the mixture.
12 μl of this solution was loaded onto a 1% agarose gel in Tris-
acetate-EDTA (TAE) buffer containing ethidium bromide for visuali-
zation of the DNA bands. The gel was run at 100 V for 30 min and
imaged on a Bio-Rad Geldoc XR (Bio-Rad Laboratories, Hercules CA).
To determine the binding afﬁnity of the puroindoline peptides to
pET-19b plasmid DNA, the density of the plasmid bands in the aga-
rose gels was determined with the Bio-Rad Quantity One imaging
software package. The resulting band intensities were plotted as a
function of deoxyribonucleotide concentration and the Kd values
were calculated with CaLigator in the same manner as the lipid bind-
ing experiments.
2.13. Macromolecular synthesis inhibition
The inhibition of DNA, RNA and protein synthesis in E. coli was
determined using the procedure described by Patrzykat et al. [44].
E. coli CGSC 4908 (auxotrophic for thymidine, uridine and L-histidine)
was obtained from the CGSC at Yale University (New Haven, CT).
Overnight cultures of CGSC 4908 were grown in LB broth starting
from a single colony selected from a fresh LB-agar streak plate. The
following day, 10 μl of the overnight culture was added to 10 ml of
LB broth and grown to the exponential phase (OD 600 nm of ~0.3).
The cells were harvested at 3220 ×g for 5 min at 4 °C and then
resuspended in an equal volume of M9 minimal media [45]. 300 μl
aliquots of resuspended cells were supplemented with 9 μl of either
[3H]thymidine, [3H]uridine or [3H]L-histidine and 100 mg/l of the
other two unlabeled precursors. The cultures were incubated for
5 min at 37 °C, at which point 3 μl of stock peptide solution was
added to achieve ﬁnal peptide concentrations of 3, 6, 30 or 60 μM.
50 μl of the bacterial culture was removed prior to the addition of
peptide (time = 0) and added to 5 ml of ice cold 10% trichloroacetic
acid (TCA) containing 200 mg/l of unlabeled precursors. This process
was repeated at time points of 5, 15 and 30 min. After 40 min on ice,
the TCA samples were transferred to a 37 °C water bath and incu-
bated for 15 min. DNA, RNA and protein were collected over vacuum
using 25 mm nucleic acid and protein transfer ﬁlters fromWhatman
GmbH (Dassel, Germany). The ﬁlters were rinsed 10 times with ice
cold 10% TCA and dried in an oven at 70 °C. Each ﬁlter was placed
in a scintillation vial with 20 ml of BCS-NA non-aqueous biodegrad-
able counting scintillant (GE Healthcare) and radioactive counts foreach sample were recorded for 1 min using a Beckman LS6500
multi-purpose scintillation counter (Beckman Coulter, Brea, CA.).
Growth assays for CGSC 4908 were performed as described above
using M9 minimal media supplemented with 100 mg/l of unlabeled
precursors. At each time point, a 5 μl aliquot of the bacterial cell sus-
pension was diluted 40,000× and 100 μl of this dilution was spread
onto LB-agar plates. The plates were incubated overnight at 37 °C
and cfus were counted the following day.
3. Results
3.1. Antimicrobial and hemolytic activity
MICs for the PuroB peptides against E. coli and S. aureus are shown
in Table 2. PuroB1, which directly corresponds to the Trp-rich region
in puroindoline B, is relatively inactive. PuroB4, in which the two pro-
line residues of PuroB1 have been replaced by Ala, is also inactive
under the conditions tested. PuroB2, PuroB3 and PuroB5 have muta-
tions to the Pro residues which introduce basic Arg and Lys residues
to the peptide sequence. All three of these peptides exhibit signiﬁcant
antimicrobial activity, with MIC values comparable to that determined
for PuroA. Given that hemolysis of red blood cells only occurred at
peptide concentrations exceeding 300 μM, the PuroB peptides are con-
sidered to have weak cytotoxic activity.
3.2. Tryptophan emission ﬂuorescence
Tryptophan emission ﬂuorescence of the PuroB peptides in a vari-
ety of membrane mimetics was performed to examine the environ-
ment surrounding the Trp residues when the peptides interact with
membranes. A blue shift in the maximum emission wavelength oc-
curs when a Trp residue moves into a more hydrophobic environment
and is typically interpreted as the indole moiety inserting into the
hydrophobic core of a bilayer. In buffer, all of the peptides had a Trp
emission maximum at ~357 nm (Table 3). When SDS or DPC micelles
were added to the peptides, a signiﬁcant blue shift was observed.
Strong blue shifts were also seen when negatively charged LUVs
were added, suggesting that an electrostatic attraction between the
anionic lipids and the cationic residues is important for lipid binding.
When mixed with ePC LUVs, none of the peptides demonstrated any
signiﬁcant blue shift, further implicating the negative charge as an es-
sential component of the peptide-lipid interactions. The blue shifts
seenwith the zwitterionic detergent DPC are likely due to the detergent
bound conformation of the PuroB peptides being favoured because of
the high concentration of detergent used in the ﬂuorescence experi-
ments as opposed to an electrostatic attractionwith themicelle surface.
3.3. Tryptophan ﬂuorescence quenching
The quenching of Trp emission ﬂuorescence by the soluble acryl-
amide quencher provides information about the accessibility of the
Trp ﬂuorophores when the peptide is bound to a membrane. If a pep-
tide binds to the surface of a membrane and the Trp residues insert
into the hydrophobic core of the bilayer, then they are no longer
Table 3
Blue shifts (in nm) of the ﬂuorescence emission maximum wavelength for the PuroB
peptides in various lipid environments. Values are indicated relative to the wavelength
of the maximum emission ﬂuorescence of each peptide in buffer (Buffer max λ). The
concentration of SDS and DPC in these experiments was 25 mM while the phospholipid
concentration in the LUV containing samples was 30 μM.
Peptide Buffer max λ Micelles LUVs
SDS DPC ePE:ePG 3:1 ePE:ePG ePC:ePG ePC
PuroB1 358 16 13 11 3 12 −1
PuroB2 357 13 11 6 2 9 2
PuroB3 357 13 8 9 5 10 0
PuroB4 357 12 13 10 2 13 0
PuroB5 357 13 9 12 7 10 0
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indicates that the ﬂuorophore is buried into the hydrophobic core of a
bilayer. The relative Ksv values for the PuroB peptides are shown in
Fig. 1. All of the Ksv results are shown as relative values compared
to the Ksv of the peptide in buffer, which has been assigned a value
of 1. Consistent with the blue shift results, all of the PuroB peptides
had similar relative Ksv values under the conditions tested. All of
the micelle bound peptides produced relative Ksv values roughly
50% lower than the values determined in buffer. When tested with
LUVs, all of the peptides displayed lower Ksv values compared to buff-
er, but the decrease in relative Ksv was directly related to the net neg-
ative charge on the surface of the vesicle. In LUVs where half of the
head groups were PG, there was a reduction in the Ksv values of
roughly 40%. This decrease was not as pronounced when the peptides
were mixed with 3:1 ePE:ePG LUVs, wherein the lower concentration
of ePG results in fewer negative charges on the surface of the vesicles.
When mixed with zwitterionic ePC LUVs, the PuroB peptides had Ksv
values that were approximately 80% of the Ksv reported in buffer.
This is likely due to a weaker interaction between the peptides and
the charge neutral vesicles.
Based on the ﬂuorescence results, the PuroB derived peptides pref-
erentially interact with negatively charged lipid species. However, all
of the peptides appear to interact with bilayers in a similar fashion
and there are no signiﬁcant differences between the peptides to explain
the variation in the MIC values.
3.4. Differential scanning calorimetry
The inﬂuence of the PuroB peptides on the thermotrophic phase
behavior of DPPC and DPPG lipid suspensions was examined with
DSC. The zwitterionic PC head group is used as a mimic for eukaryoticFig. 1. Relative Ksv values calculated for the PuroB peptides in various lipid environ-
ments. The average Ksvs of the peptide determined in buffer was arbitrarily assigned
a value of 1 and the error bars represent the standard deviation of three separate trials.
The concentration of SDS and DPC in these experiments was 25 mM while the phos-
pholipid concentration in the LUV containing samples was 30 μM.membranes while the negatively charged PG head group is repre-
sentative of bacterial membranes [46]. None of the PuroB peptides
caused signiﬁcant changes in the DSC thermograms of DPPC lipids
at peptide:lipid ratios of 1:10. The main phase transition of pure
DPPC occurs at ~41 °C and it was relatively unaffected by the addition
of any of the PuroB peptides (Fig. 2).
The addition of the PuroB peptides to DPPG lipid suspensions had a
much stronger effect on the thermotrophic phase behaviour of the an-
ionic phospholipids (Fig. 3). Pure DPPG lipids showed a pre-transition
at ~33 °C and a main phase transition at ~40 °C. The addition of
PuroB1 and PuroB4 to DPPG lipids caused the pre-transition to disap-
pear and the main phase transition broadened slightly and shifted to a
lower temperature of ~38 °C. The addition of PuroB2 had a similar ef-
fect, except that there appears to be two peaks comprising the main
phase transition at 38 °C. This suggests that these peptides insert into
the hydrophobic core of DPPG bilayers and destabilize the phase transi-
tion between the lamellar gel phase and the liquid crystalline phase.
The addition of PuroB3 and PuroB5 to DPPG lipid suspensions
resulted in the largest changes in the DSC thermograms compared
to the pure lipid. Whenmixed with PuroB3, the heating scan showed
a main phase transition centered at ~38 °C and a small peak at
~43.5 °C. When PuroB5 was added, it virtually abolished the main
phase transition peak and a high temperature transition at ~56 °C
appeared. The higher temperature transitions in the presence of
PuroB3 and PuroB5 suggest the formation of stable lipid–peptide
complexes that behave differently compared to pure DPPG or any
of the other peptides. Evidently the cationic residues at position
two in PuroB3 and PuroB5 do not impede membrane insertion of
the N-terminal region of the peptides. Instead, it appears that this
added positive charge causes signiﬁcant changes in bilayer organiza-
tion. In general, the DSC results demonstrate that the PuroB peptides
interact with negatively charged phospholipids and all of them insert
into the acyl chains of the bilayer.Fig. 2. Differential scanning calorimetry thermograms of a 0.5 mg/ml DPPC lipid suspen-
sion and DPPC mixed with the PuroB peptides added at a lipid:peptide ratio of 10:1. The
insets show a magniﬁcation of the pretransition region of the DSC scan and the vertical
dashed line at ~41 °C corresponds to the main phase transition temperature (Tm) of the
lamellar gel phase to the liquid crystalline phase of pure DPPC.
Fig. 3. DSC thermograms of 0.5 mg/ml DPPG lipid compared to DPPG mixed with the
PuroB peptides at a ﬁnal lipid:peptide ratio of 10:1. The vertical dashed line at
~40 °C corresponds to the Tm of pure DPPG.
Fig. 4. Inﬂuence of the PuroB peptides on the liquid crystalline to inverted hexagonal
phase transition temperature (Thex) of DiPoPE lipids. A DSC scan of pure DiPoPE is
shown for comparison. The Thex of pure DiPoPE is 42.6 °C and the transition tempera-
tures for the peptide containing samples are indicated. The concentration of lipid in
each sample was 5 mg/ml and a molar lipid:peptide ratio of 10:1 was used.
Fig. 5. Circular dichroism spectra of the puroindoline derived peptides in buffer (♦) and in
the presence of 30 mM SDS (□). All spectra were recorded at a peptide concentration of
50 μM at room temperature.
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induce membrane curvature by monitoring the shift in the liquid
crystalline (Lα) to inverted hexagonal phase transition (HII) [47,48].
The effect of the PuroB peptides on the hexagonal phase transition
temperature (Thex) of DiPoPE lipids was evaluated using DSC
(Fig. 4). Usually, an increase in the Thex is consistent with an induction
of positive membrane curvature which is often associated with the
formation of pores in a bilayer [49]. Interestingly, while all of the
PuroB peptides shifted the Thex to a higher temperature, none of the
PuroB peptide signiﬁcantly destabilized model membranes or E. coli
cytoplasmic membranes (see calcein leakage and membrane depolar-
ization results below). Therefore, another interpretation of the ob-
served increase in the Thex by the PuroB peptides is that these
peptides stabilize the lamellar phase of DiPoPE lipids. This would in-
hibit the formation of the inverse hexagonal lipid phase and shift
the Thex to a higher temperature but would also explain why the pep-
tides do not destabilize the integrity of bilayers. To the best of our
knowledge, this is the ﬁrst example of a peptide that increases the
Thex of DiPoPE lipids but does not induce pores in phospholipid
bilayers.
3.5. Circular dichroism spectroscopy
Circular dichroism spectra of the puroindoline peptides were
recorded in buffer and in the presence of SDS micelles (Fig. 5). In
buffer, all of the puroindoline B peptides had strong negative peaks
at ~200 nm, indicative of unstructured peptides. There is also a strong
peak at ~223 nm in all the spectra which is likely due to interactions
between neighbouring Trp residues in the peptides [50]. When
SDS micelles were added to the samples, all of the PuroB peptides
underwent a conformational change, as seen by the emergence of a
new minima peak at ~226 nm. In addition, all of the PuroB peptides,
except PuroB4, saw another positive peak appear at ~215 nm. For
PuroB4, an increase in the mean residue ellipticity (MRE) valuesnear 195 nm was observed. Additionally, the CD spectrum of
PuroB1 in SDS retains a relatively strong minima at 200 nm which
could be due to the presence of multiple peptide conformations with-
in the sample (see NMR structure section below).
Overall, the CD spectral features of the PuroB peptides bound to
SDS micelles are not characteristic of any type of regular secondary
structure element (ie. α-helix or β-sheet) but the increase in MRE
at 210 nm might be due to the presence of β-turn conformations
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to each other, we can conclude that they all adopt similar SDS bound
conformations that are different from their structures in aqueous
solution. In contrast, the CD spectrum of PuroA in the presence of
SDS micelles is remarkably similar to that observed in buffer
(Fig. 5), suggesting that PuroA does not undergo a large conformational
change when it binds to membranes.Fig. 6. NMR solution structures of PuroB2, PuroB3, PuroB4 and PuroB5 bound to SDS
micelles. The panel on the left highlights speciﬁc residues with hydrophobic residues
shown in grey, Thr indicated in orange and positively charged residues coloured
blue. The panel on the right depicts the surface charge distribution of the PuroB
peptides with positively charged regions shown in blue.3.6. Micelle bound NMR solution structures of PuroB peptides
Consistent with the CD results, all of the PuroB peptides appeared
to be unstructured in aqueous solution based on the lack of cross
peaks in the NOESY spectra (data not shown). Upon the addition of
deuterated SDS micelles, the PuroB peptides underwent a confor-
mational change to a micelle bound state. The NOESY spectra of
PuroB2, B3, B4 and B5 in the presence of SDS were all well resolved
with excellent peak separation. In the case of PuroB1, the presence
of the two Pro residues signiﬁcantly complicated the NMR structural
analysis. It appears that cis-trans isomerisation across these two Pro
residues yielded multiple conformations for micelle bound PuroB1
(see Supplementary Fig. 1). Considering that PuroB1 displayed poor
antimicrobial activity (Table 2) and that the conformation was similar
to the other puroindoline B derived peptides (see CD spectroscopy
results), the NMR structure of micelle bound PuroB1 was not pursued
further.
The solution structures of the remaining PuroB peptides bound to
SDS micelles are shown in Fig. 6. Structural statistics for resulting
structures are shown in Supplementary Table 1. All four peptides
adopt extended conformations with well deﬁned backbone RMSDs
ranging from ~0.3 to 0.6 Å when the structures are superimposed
across residues 2–11. The structures of the PuroB peptides bound to
SDS micelles are largely amphipathic with Phe1, Val3 and the three
Trp residues forming a large hydrophobic surface on one face of the
peptide, while the cationic and hydrophilic residues (Arg, Lys and Thr)
appear on the opposite face. The exception to this is the positively
charged Arg6 in PuroB3 which is oriented directly in the middle of the
hydrophobic face of the peptide. Upon closer inspection, the indole
ring of Trp5 is parallel to the Arg side chain, suggesting that there
could be a cation–pi interaction between these two residues (e.g. see
Chan et al. [52]). This interaction likely shields some of the positive
charge of the guanidinium group from the negatively charged micelles
while still allowing for the peptide to interact with membranes.
The solution structures of the PuroB peptides shown here suggest
a binding model wherein the peptide inserts at the interfacial region
of a negatively charged membrane. Based on this structure, the
hydrophobic residues penetrate into the hydrophobic core of the
membrane while the positive charges interact with the negative
charges of the lipid head groups.3.7. Calcein leakage
The PuroB peptides as well as PuroA were examined for their abil-
ity to induce leakage of the self quenching dye, calcein, from LUVs
of varying composition. Melittin, a peptide with known membrane
destabilizing activity, was used as a positive control for membrane
leakage. Interestingly, the percent of calcein leakage induced by the
PuroB peptides was comparable to the intrinsic leakage of the LUVs
over the course of the experiment, suggesting that the PuroB peptides
do not disrupt the integrity of phospholipid bilayers under the condi-
tions tested (Fig. 7A). PuroA caused signiﬁcant leakage from LUVs
composed of DPPC:DPPG, ePC or ePC:ePG while very little calcein
release was observed from vesicles composed of DPPC or PLE. This
suggests that the membrane perturbing properties of PuroA are
dependent on the type of phospholipid that makes up the vesicles.3.8. Membrane depolarization of E.coli DC2
The capacity of the puroindoline derived peptides to depolarize
the cytoplasmic membrane of E. coli DC2 cells was examined and
compared to the depolarization caused by the lytic peptide, melittin.
All of the PuroB peptides as well as PuroA caused signiﬁcantly less
depolarization of the bacterial cytoplasmic membrane compared to
melittin (Fig. 7B). While it is unknown what amount of membrane
depolarization correlates with the determined MICs, it is evident
that the puroindoline peptides do not depolarize the bacterial cyto-
plasmic membrane to the same extent as melittin.
3.9. DNA binding by inhibition of plasmid migration in an agarose gel
DNA binding by the PuroB peptides was indirectly measured by
monitoring the effect of increasing peptide concentration on the
migration of puriﬁed pET-19b plasmid DNA in a 1 % agarose gel
(Fig. 8). PuroB1 demonstrated the weakest ability to inhibit plasmid
migration since strong DNA bands were still observed at peptide:
plasmid weight ratios as high as 30:1. PuroB4 had the next lowest ca-
pacity to inhibit plasmid DNA migration with strong plasmid bands
still present at ratios as high as 10:1 with weaker bands observed at
20:1 and 30:1 as well. PuroB2, PuroB3 and PuroB5 all had stronger
DNA binding afﬁnities compared to PuroB1 and PuroB4. PuroB2
showed signiﬁcant inhibition of DNA migration at peptide:DNA ratios
higher than 10:1, PuroB3 stopped DNA migration at a ratio of 5:1 and
PuroB5 inhibited DNAmigration at a weight ratio of 1:1, the strongest
Fig. 7.Membraneperturbation caused by thepuroindoline derivedpeptides. (A) Percentage
of calcein dye release from LUVs by the PuroB peptides, PuroA and melittin. Peptides were
added to achieve a ﬁnal lipid:peptide molar ratio of 10:1. The lipid composition for each
LUV is indicated and error bars represent the standard deviation of three separate trials.
(B) Percent membrane depolarization of E. coli DC-2 cells induced by the PuroB peptides
and PuroA at a concentration of 6 μM. The membrane depolarization induced by 20 μM
melittin has been assigned a maximal depolarization value of 100%. Error bars represent
the standard deviation of four separate trials.
Fig. 8. Inhibition of pET-19b plasmid migration in a 1% agarose gel by the puroindoline
peptides. Peptide and plasmid were incubated at room temperature for 1 h at increasing
peptide:plasmid weight ratios, indicated at the top of each lane. Pure pET-19b plasmid
was also run as a negative control in lane 2.
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exhibited a strong capacity to bind to plasmid DNA as pET-19b bands
could not be seen at weight ratios above 1:1.
3.10. Dissociation constants for peptide binding to DNA and phospholipids
The dissociation constants (Kds) calculated for the puroindoline
derived peptides binding to pET-19b plasmid DNA or E. coli polar
lipid extract LUVs are shown in Table 4. The DNA binding Kds are
reported per deoxyribonucleotide base while the lipid binding Kds
are per phospholipid. For an example and complete description of
the calculations used to determine the Kds for DNA and E. coli polar
lipid binding, see Supplementary Fig. S2. All of the lipid binding afﬁn-
ities were similar for all of the PuroB peptides with values ranging
from ~20 to 40 μM, representing relatively weak lipid binding. The
dissociation constants determined for the PuroB peptides binding to
DNA were more varied. The strongest binding peptides were PuroB2,
PuroB3 and PuroB5 with average Kd values between 2 and 10 μM.
This is 5–20 times stronger than the afﬁnities determined for lipid
binding. Conversely, PuroB1 and PuroB4 bound deoxyribonucleotides
weakly. The Kd values determined for PuroA binding to both DNA and
lipids were the strongest of all the peptides tested.
A comparison between the two calculated Kd values gives an indica-
tion as to which biomolecule the puroindoline peptides preferentially
bind. In the case of PuroB1 and PuroB4, the Kds for DNA and lipid bind-
ing are roughly equivalent (within error) which demonstrates that
there is no preference for binding. For all the other peptides, their afﬁn-
ities for DNA were 2 to 10 times stronger, suggesting that it is more
favorable for these peptides to bind to DNA than membranes.
3.11. Macromolecular synthesis inhibition
E. coli CGSC 4908 is a bacterial strain auxotrophic for thymidine,
uridine and L-histidine [53]. The incorporation of radioactive ver-
sions of these precursors into DNA, RNA and protein was monitored
over time in the presence of the puroindoline derived peptides
and compared to cultures grown in the absence of peptide. Control
experiments were performed with ciproﬂoxacin, rifampin and chlor-
amphenicol as inhibitors of DNA, RNA and protein synthesis respec-
tively (See Supplementary Fig. S3).
Based on the MIC values determined for E. coli in Table 2, peptide
concentrations of 3, 6, 30 and 60 μM were examined for their ability
to kill E. coli CGSC 4908 over the course of the 30 min incubation.
These concentrations were chosen because they cover all of the MIC
values for the most active peptides that were tested with the tritiated
compounds. The effects of PuroB1 and PuroB4 on macromolecular
synthesis in E. coli CGSC 4908 were not determined because these
two peptides were inactive in this concentration range.
Of the peptides tested in this study, PuroA was the most potent
against E. coli ATCC 25922 (Table 2). When examined against CGSC
4908, PuroA caused almost 100% death after 30 min of incubation at
peptide concentrations of 30 and 60 μM. Even at low peptide concen-
trations of 3 and 6 μM, only ~10% of the bacterial cells survived the
incubation with PuroA. These two lowest peptide concentrationsTable 4
Dissociation constants (Kds) for the puroindoline derived peptides binding to pET-19b
plasmid DNA and E. coli polar lipid extract LUVs. Error ranges are the standard deviation
of three separate experiments.
Peptide DNA Kd (μM) Lipid Kd (μM) Ratio lipid Kd:DNA Kd
PuroB1 53.0 ± 3.5 42.4 ± 2.9 0.8
PuroB2 9.6 ± 11.9 41.1 ± 6.1 4.3
PuroB3 3.1 ± 4.5 19.6 ± 3.6 6.4
PuroB4 20.7 ± 8.2 36.6 ± 11.1 1.8
PuroB5 2.3 ± 0.2 23.8 ± 6.0 10.4
PuroA 0.4 ± 0.2 1.0 ± 0.1 2.2
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that PuroA blocked the incorporation of tritiated precursors of DNA,
RNA and protein (Fig. 9). This effect was almost immediate as there
was a distinct drop in the radioactive counts for samples taken after
5 min of incubation with the peptide.
The PuroB2, PuroB3 and PuroB5 peptides were also tested for their
ability to inhibit macromolecular synthesis in E. coli. Over the course
of 30 min incubation, PuroB2 did not kill a signiﬁcant amount, even
at a concentration as high as 60 μM (Fig. 9). In spite of the lack of
killing, PuroB2 did block the incorporation of tritiated precursors
into DNA, RNA and protein in a concentration dependent manner.
Even at a sub-MIC concentration of 6 μM, PuroB2 caused a slight
decrease in the amount of DNA, RNA and protein generated in the E.
coli cultures. When the peptide concentration was increased to 30
and 60 μM, a more substantial decrease in the amount of DNA, RNA
and protein was observed.Fig. 9. Effect of the puroindoline peptides on bacterial survival and macromolecular synthe
peptide concentrations of 3(▲), 6(●), 30(□) and 60 μM(○). The effect of peptide on the
into protein was also measured and compared to a control sample lacking peptide (■). D
from two separate trials are shown.PuroB3 and PuroB5 both have MICs of ~6 μM against E. coli and
they demonstrated similar abilities to inhibit macromolecular synthe-
sis in vivo (Fig. 9). After 30 min of incubation with both peptides, less
than 10% survival was observed at concentrations of 60 μM so this
concentration was not tested in the macromolecular synthesis assays.
At lower peptide concentrations, where a number of E. coli cells sur-
vived the 30 minute incubation, there was a substantial decrease in
the amount of DNA, RNA and protein that was produced. Even at a
peptide concentration of 3 μM, which is below the MIC, both PuroB3
and PuroB5 caused a decrease in the production of DNA, RNA and
protein. At 30 μM, both PuroB3 and PuroB5 blocked the incorporation
of tritiated thymidine, uridine and histidine into DNA, RNA and pro-
tein similar to the effects observed with the control antibiotics.
The macromolecular synthesis assays presented here demonstrate
that the PuroB peptides are capable of blocking synthesis of DNA,
RNA and protein in bacterial cells. This correlates with the observedsis in E. coli CGSC 4908. Bacterial survival in the presence of peptide was examined at
incorporation of [3H]-thymidine into DNA, [3H]-uridine into RNA and [3H]L-histidine
ata are presented as radioactive counts per minute (CPM) and representative results
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mode of action.
4. Discussion
The mode of action of many antimicrobial peptides is usually at-
tributed to the perturbation of the bacterial cytoplasmic membrane
which directly leads to the release of cellular components and cell
death [1]. Most of the biophysical studies presented here are consis-
tent with the binding of the puroindoline B derived peptides to neg-
atively charged membranes, which implicates lipid binding as a step
in the mode of action of the PuroB peptides.
All the PuroB peptides were relatively unstructured in aqueous so-
lution and only folded in the presence of detergent micelles, where
they adopted a largely amphipathic turn-like structure (Fig. 6). Two
antimicrobial peptides with similar amino acid composition to the
puroindoline derived peptides are tritrpticin and indolicin. These an-
timicrobial peptides are also rich in Trp residues and exhibit a large
net cationic charge [52]. Interestingly, both of these peptides adopt
stable turn-like structures in the presence of detergent micelles
[20,54] and it is possible that this is a feature of Trp-rich cationic an-
timicrobial peptides.
The emission ﬂuorescence results suggest that the PuroB peptides
interact at the interfacial region of a bilayer and that the Trp residues
embed themselves into the hydrophobic core of the membrane. The
DSC results demonstrated that the PuroB peptides selectively interact
with anionic phospholipids but they also increase the Thex in DiPoPE
lipid suspensions. All of these results are consistent with a membrane
active mode of action [49,52] that was previously proposed for the
related PuroA peptide [21]. However, the calcein leakage and mem-
brane depolarization assay clearly demonstrate that the PuroB
peptides do not signiﬁcantly disrupt the integrity of phospholipid bi-
layers to the same levels seen for other membrane active peptides.
As a result, an alternative molecular target for the PuroB derived
peptides was sought.
The idea of non-membrane targeting by antimicrobial peptides
has been postulated for some time [55–57] and experimental evi-
dence for intracellular targets continues to appear in the literature.
Indirect evidence comes from confocal microscopy studies of ﬂuores-
cently tagged peptides wherein the peptides cross the bacterial mem-
brane and localize within the cytoplasm [5,58,59], suggesting that
these peptides exert their antimicrobial effect intracellularly. Data
supporting direct interactions between antimicrobial peptides and
intracellular components is also available. For instance, buforin II,
a highly potent antimicrobial peptide produced in the stomach tissue
of the Asian toad Bufo bufo garagriozans [60], has higher antimicrobial
activity than the well known lytic peptide, magainin 2, but it does not
effectively permeabilize membranes [61]. Instead, Buforin II translo-
cates across membranes without causing signiﬁcant lipid ﬂip-ﬂop
[61] and localizes to the cytoplasm of bacterial cells [43]. Buforin II
is also known to interact with DNA and RNA [43], offering compelling
evidence that this antimicrobial peptide acts intracellularly. It should
be noted that buforin II is derived from histone H2A [60]. Histones are
highly basic proteins responsible for DNA packing in eukaryotic nu-
clei and therefore, the ability of buforin II to interact with DNA may
be an intrinsic trait of this sequence. However, non-histone derived
antimicrobial peptides have also been shown to bind directly to
DNA [62] and RNA [63] suggesting that this may be a general feature
of a number of antimicrobial peptide sequences.
Recently, novel intracellular binding targets for antimicrobial pep-
tides have been identiﬁed which implicate non-membrane mediated
mechanisms of action as the primary cause of bacterial cell death.
Examples include direct inhibition of DNA repair machinery within
the bacterial cell [64] or interactions between antimicrobial peptides
and ATP, which sequesters the high energy molecule from the activity
of ATP-dependent enzymes [65]. Proteomics approaches have alsobeen used to identify protein binding targets for antimicrobial peptides
[66]. It is becoming increasingly apparent that intracellular targeting by
antimicrobial peptides may be part of a complex combination of factors
that all contribute to the antimicrobial mechanism of action.
The agarose gel retardation assays presented here reveal that the
PuroB peptides are capable of binding plasmid DNA. Of particular in-
terest is that the most potent antibacterial PuroB peptides, B2, B3 and
B5, have the greatest afﬁnity for the plasmid DNA. Additionally, the
afﬁnity of PuroB2, B3 and B5 for the plasmid DNA is stronger than
the afﬁnity of these peptides to lipids (Table 4), suggesting that
these peptides would prefer to bind to DNA over phospholipids.
These results correlate well with the observed antimicrobial activities
of the PuroB peptides and it is attractive to propose a mechanism
of antimicrobial activity wherein the puroindoline derived peptides
spontaneously translocate into the cytoplasm of bacterial cells and
bind to nucleic acids within the cell. Unfortunately, the agarose gel re-
tardation assay is not direct evidence that these peptides block tran-
scription and translation in vivo. PuroB2, B3 and B5 have the largest
cationic charge of all the PuroB derivatives and it is possible that the
positively charged peptides are interacting with the polyanionic
DNA similar to the electrostatic attraction between the peptides and
negatively charged membranes.
To establish a link between the DNA binding assay and the antimi-
crobial activity of the PuroB peptides, we performed macromolecular
synthesis inhibition assays using radioactive precursors for DNA, RNA
and protein biosynthesis and monitored isotope incorporation over
time. Similar experiments have been applied to macromolecular syn-
thesis studies of bacteria grown in the presence of bovine lactoferricin
[67], indolicidin [68], lysozyme derived peptides [69] and pleurocidin
derived peptides [44]. When tested at concentrations near the MIC,
PuroB2, PuroB3 and PuroB5 caused a rapid and substantial decrease
in the amount of radioactive precursor incorporated into DNA, RNA
and protein. This demonstrates that the PuroB peptides inhibit the
processes of transcribing the DNA strand into mRNA, the translation
of the mRNA into protein and DNA replication itself.
Notably, PuroA also signiﬁcantly inhibited macromolecular synthe-
sis at sub-inhibitory concentrations of the peptide (Fig. 9). Previous
experiments showed that PuroA signiﬁcantly caused calcein leakage
from POPC:POPG LUVs [21] but the current work indicates that this
membrane disrupting property depends on the ﬂuidity of the mem-
brane and the degree of saturation in the acyl chains (see Fig. 7B). Addi-
tionally, PuroA does not appear to disrupt cytoplasmic membrane
integrity in E. coli cells, suggesting that the antibacterial activity may
be more complex than originally postulated. The interaction between
PuroA and the bacterial membrane is probably an intermediate step in
the mechanism of action of this peptide. PuroA likely initially interacts
with the bacterial phospholipids followed by translocation into the
bacterial cell, where it ultimately exerts its antibacterial effect.
It is possible that intracellular mechanisms of action have been
overlooked in other antimicrobial peptide studies. If a peptide dem-
onstrates signiﬁcant pore forming or lytic properties, then one of
the conventional membrane destabilizing models [1,49,52] is usually
applied to explain the observed activity. However, in instances where
a peptide does not cause signiﬁcant membrane destabilization, only
then are other binding targets sought to explain the mode of action.
The results from the studies with the PuroA peptide clearly demon-
strate that a strong membrane destabilizing effect does not necessar-
ily preclude additional mechanisms, such as binding to intracellular
DNA, RNA or proteins.
Predicting whether a peptide sequence will be predominantly
membrane active or act intracellularly is not a trivial endeavor.
Many studies into the biological effect of tritrpticins and indolicidins
have focused on membrane interactions, implicating a membrane
mode of action for these peptides [70–75]. However, our group
has recently discovered that tritrpticin can bind to plasmid DNA
(unpublished results) and there is signiﬁcant evidence that indolicidin
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derived from lysozyme cause minimal membrane perturbations [5]
while causing rapid inhibition of macromolecular synthesis in E. coli
[69]. This feature may not be limited to Trp-rich peptides with
turn-like structures. For instance, magainin 2 is a peptide that adopts
helical structure in the presence of micelles [76] but it has also been
shown to enter bacterial cells [77] and has the ability to bind DNA and
RNA [43], albeit with lower afﬁnity compared to other peptides [78].
This observation further highlights the importance of comparing the
strength of peptide binding to intracellular components compared to
the afﬁnity of the peptide to phospholipids.
The structural requirements for antimicrobial peptide binding to
DNA have only recently been examined for a handful of peptides.
A molecular dynamics simulation of buforin II bound to nucleic
acids revealed that positively charged residues form strong interac-
tions with the phosphate groups in the nucleic acid backbone [79].
Considering that the phosphodiester backbone is integral to DNA
sequences, the authors hypothesized that buforin II targets DNA
in a non-sequence speciﬁc manner [79]. The molecular dynamics
simulations of buforin II also suggested that the peptide maintained
a helical conformation when bound to DNA. However, a circular di-
chroism study revealed that buforin II actually adopts an extended
conformation when bound to DNA [78]. In addition to buforin II,
the structures of magainin 2 and pleurocidin bound to duplex DNA
and membranes were also studied by CD spectroscopy. Interesting-
ly, these two peptides more readily adopted α-helical conforma-
tions when bound to membranes compared to buforin II. However,
the afﬁnity of magainin 2 and pleurocidin for DNA was weaker
than that seen with buforin II, leading the authors to conclude that
peptide helicity is likely directly related to membrane activity but
does not contribute to interactions with duplex DNA [78]. Evidently,
more structural studies of antimicrobial peptide binding to DNA are
required to fully understand the interactions that are occurring at
the molecular level.
The results presented here for the puroindoline derived antimi-
crobial peptides reveal a mode of action that combines membrane
interactions with intracellular targeting. Our current model for the
mechanism of action involves the PuroB peptides partitioning into
negatively charged membranes where they adopt a largely amphi-
pathic structure with the Trp residues embedded into the hydropho-
bic core of the membrane. Interestingly, the PuroB peptides do not
disrupt membranes to a large enough extent to allow for leakage of
calcein from LUVs or extensive membrane depolarization. Instead,
it appears that the PuroB peptides translocate across the bacterial
membrane where they preferentially bind to nucleic acids within
the cell and block the synthesis of DNA, RNA and proteins. Various
mechanisms of peptide translocation have been proposed which do
not involve disruption of the overall integrity of the bacterial cyto-
plasmic membrane [28,49] but the exact mechanism of PuroB mem-
brane translocation remains to be elucidated.
The biophysical studies of the PuroB derivatives have signiﬁcant
implications for antimicrobial peptide research in general. Most
studies reported to date have focused on understanding the in-
teractions between antimicrobial peptides and membranes and
thus far only limited attention has been devoted to intracellular
targeting of antimicrobial peptides. Identifying novel targets for
antimicrobial peptides and understanding their underlying molec-
ular interactions are important aspects for future research into
antimicrobial peptides. Eventually, the current efforts to enhance
membrane interactions and translocation might one day be aug-
mented by efforts to strengthen the molecular interactions be-
tween antimicrobial peptides and DNA, RNA or proteins. Ultimately,
generating truly novel and potent antimicrobial sequences will
require optimizing peptide sequences that efﬁciently pass through
membranes and simultaneously bind strongly to intracellular
components.Acknowledgements
The authors would like to thank Dr. Deane McIntyre for his dedica-
tion and service to the NMR facility at the University of Calgary. Thanks
also to Dr. Kasia Stevens for assistance with the radioactive assays and
Dr. Leonard T. Nguyen and Mauricio Arias for helpful discussions. This
work was supported by the Canadian Institutes of Health Research
(CIHR) program for “Alternatives to Antibiotics” (HJV) and by the
Natural Sciences and Engineering Research Council (NSERC) discovery
grant 293595-07 (DGS). HJV is an Alberta Innovates–Health Solutions
(AIHS) Scientist.Appendix A. Supplementary data
Supplementary data to this article can be found online at http://
dx.doi.org/10.1016/j.bbamem.2013.03.023.References
[1] L.T. Nguyen, E.F. Haney, H.J. Vogel, The expanding scope of antimicrobial peptide
structures and their modes of action, Trends Biotechnol. 29 (2011) 464–472.
[2] W. Bellamy, M. Takase, H. Wakabayashi, K. Kawase, M. Tomita, Antibacterial spec-
trum of lactoferricin-B, a potent bactericidal peptide derived from the N-terminal
region of bovine lactoferrin, J. Appl. Bacteriol. 73 (1992) 472–479.
[3] J.L. Gifford, H.N. Hunter, H.J. Vogel, Lactoferricin: a lactoferrin-derived peptide
with antimicrobial, antiviral, antitumor and immunological properties, Cell.
Mol. Life Sci. 62 (2005) 2588–2598.
[4] M.I.A. van der Kraan, J. Groenink, K. Nazmi, E.C.I. Veerman, J.G.M. Bolscher, A.V.N.
Amerongen, Lactoferrampin: a novel antimicrobial peptide in the N1-domain of
bovine lactoferrin, Peptides 25 (2004) 177–183.
[5] H.N. Hunter, W. Jing, D.J. Schibli, T. Trinh, I.Y. Park, S.C. Kim, H.J. Vogel, The inter-
actions of antimicrobial peptides derived from lysozyme with model membrane
systems, Biochim. Biophys. Acta 1668 (2005) 175–189.
[6] H. Kawasaki, S. Iwamuro, Potential roles of histones in host defense as antimicro-
bial agents, Infect. Disord. Drug Targets 8 (2008) 195–205.
[7] H.S. Tsao, S.A. Spinella, A.T. Lee, D.E. Elmore, Design of novel histone-derived
antimicrobial peptides, Peptides 30 (2009) 2168–2173.
[8] J.E. Blochet, C. Chevalier, E. Forest, E. Pebay-Peyroula, M.F. Gautier, P. Joudrier, M.
Pezolet, D. Marion, Complete amino acid sequence of puroindoline, a new basic
and cystine-rich protein with a unique tryptophan-rich domain, isolated from
wheat endosperm by Triton X-114 phase partitioning, FEBS Lett. 329 (1993)
336–340.
[9] M.F. Gautier, M.E. Aleman, A. Guirao, D. Marion, P. Joudrier, Triticum aestivum
puroindolines, two basic cystine-rich seed proteins: cDNA sequence analysis
and developmental gene expression, Plant Mol. Biol. 25 (1994) 43–57.
[10] P. Charnet, G. Molle, D. Marion, M. Rousset, V. Lullien-Pellerin, Puroindolines form
ion channels in biological membranes, Biophys. J. 84 (2003) 2416–2426.
[11] C.F. Morris, Puroindolines: the molecular genetic basis of wheat grain hardness,
Plant Mol. Biol. 48 (2002) 633–647.
[12] A. Nadolska-Orczyk, S. Gasparis, W. Orczyk, The determinants of grain texture in
cereals, J. Appl. Genet. 50 (2009) 185–197.
[13] L. Dubreil, T. Gaborit, B. Bouchet, D.J. Gallant, W.F. Broekaert, L. Quillien, D.
Marion, Spatial and temporal distribution of the major isoforms of puroindolines
(puroindoline-a and puroindoline-b) and non speciﬁc lipid transfer protein
(ns-LTPle(1)) of Triticumaestivum seeds. Relationships with their in vitro antifungal
properties, Plant Sci. 138 (1998) 121–135.
[14] D. Palumbo, M. Iannaccone, A. Porta, R. Capparelli, Experimental antibacterial
therapy with puroindolines, lactoferrin and lysozyme in Listeria monocytogenes
infected mice, Microbes Infect. 12 (2010) 538–545.
[15] X. Cheng, G. Liu, G. Ye, H. Wang, X. Shen, K. Wu, J. Xie, I. Altosaar, Screening and
cloning of antimicrobial DNA sequences using a vital staining method, Gene
430 (2009) 132–139.
[16] R. Capparelli, I. Ventimiglia, D. Palumbo, D. Nicodemo, P. Salvatore, M.G. Amoroso,
M. Iannaccone, Expression of recombinant puroindolines for the treatment of
staphylococcal skin infections (acne vulgaris), J. Biotechnol. 128 (2007) 606–614.
[17] P. Llanos, M. Henriquez, J. Minic, K. Elmorjani, D. Marion, G. Riquelme, J. Molgo, E.
Benoit, Puroindoline-a and alpha1-purothionin form ion channels in giant
liposomes but exert different toxic actions on murine cells, FEBS J. 273 (2006)
1710–1722.
[18] M.E. Selsted, M.J. Novotny, W.L. Morris, Y.Q. Tang, W. Smith, J.S. Cullor,
Indolicidin, a novel bactericidal tridecapeptide amide from neutrophils, J. Biol.
Chem. 267 (1992) 4292–4295.
[19] C. Lawyer, S. Pai, M. Watabe, P. Borgia, T. Mashimo, L. Eagleton, K. Watabe,
Antimicrobial activity of a 13 amino acid tryptophan-rich peptide derived from
a putative porcine precursor protein of a novel family of antibacterial peptides,
FEBS Lett. 390 (1996) 95–98.
[20] D.J. Schibli, P.M. Hwang, H.J. Vogel, Structure of the antimicrobial peptide tritrpticin
bound to micelles: a distinct membrane-bound peptide fold, Biochemistry 38
(1999) 16749–16755.
1813E.F. Haney et al. / Biochimica et Biophysica Acta 1828 (2013) 1802–1813[21] W. Jing, A.R. Demcoe, H.J. Vogel, Conformation of a bactericidal domain of
puroindoline a: structure and mechanism of action of a 13-residue antimicrobial
peptide, J. Bacteriol. 185 (2003) 4938–4947.
[22] E. Gasteiger, C. Hoogland, A. Gattiker, S. Duvaud, M.R. Wilkins, R.D. Appel, A.
Bairoch, J.M. Walker, Protein identiﬁcation and analysis tools on the ExPASy
Server, The Proteomics Protocols Handbook, Humana Press, Totowa, NJ, 2005,
pp. 571–601.
[23] I. Andre, S. Linse, Measurement of Ca2+-binding constants of proteins and
presentation of the CaLigator software, Anal. Biochem. 305 (2002) 195–205.
[24] J.R. Lakowicz, Quenching of Fluorescence, Principles of Fluorescence Spectroscopy,
vol. Second, Kluwer Academic, New York, NY, 1999, pp. 237–265.
[25] E.F. Haney, F. Lau, H.J. Vogel, Solution structures and model membrane interac-
tions of lactoferrampin, an antimicrobial peptide derived from bovine lactoferrin,
Biochim. Biophys. Acta 1768 (2007) 2355–2364.
[26] D.J. Schibli, R.F. Epand, H.J. Vogel, R.M. Epand, Tryptophan-rich antimicrobial
peptides: comparative properties and membrane interactions, Biochem. Cell
Biol. 80 (2002) 667–677.
[27] E.J. Prenner, R.N.A.H. Lewis, L.H. Kondejewski, R.S. Hodges, R.N. McElhaney,
Differential scanning calorimetric study of the effect of the antimicrobial peptide
gramicidin S on the thermotropic phase behavior of phosphatidylcholine,
phosphatidylethanolamine and phosphatidylglycerol lipid bilayer membranes,
Biochim. Biophys. Acta 1417 (1999) 211–223.
[28] J.P.S. Powers, A. Tan, A. Ramamoorthy, R.E.W. Hancock, Solution structure and inter-
action of the antimicrobial polyphemusins with lipid membranes, Biochemistry 44
(2005) 15504–15513.
[29] B.A. Wallace, R.W. Janes, An Introduction to Circular Dichroism and Synchrotron
Radiation Circular Dichroism Spectroscopy, in: P.I. Haris (Ed.), Modern Techniques
for Circular Dichroism and Synchrotron Radiation Circular Dichroism Spectroscopy,
IOS Press, Amsterdam, 2009, pp. 1–18.
[30] T.L. Hwang, A.J. Shaka, Water suppression that works— excitation sculpting using
arbitrary wave-forms and pulsed-ﬁeld gradients, J. Magn. Reson. A 112 (1995)
275–279.
[31] F. Delaglio, S. Grzesiek, G.W. Vuister, G. Zhu, J. Pfeifer, A. Bax, Nmrpipe — a
multidimensional spectral processing system based on unix pipes, J. Biomol.
NMR 6 (1995) 277–293.
[32] B.A. Johnson, Using NMRView to visualize and analyze the NMR spectra of
macromolecules, Methods Mol. Biol. 278 (2004) 313–352.
[33] A.T. Brunger, P.D. Adams, G.M. Clore, W.L. Delano, P. Gros, R.W. Grosse-Kunstleve,
J.S. Jiang, J. Kuszewski, M. Nilges, N.S. Pannu, R.J. Read, L.M. Rice, T. Simonson, G.L.
Warren, Crystallography & NMR system: A new software suite for macromolecu-
lar structure determination, Acta Crystallogr. D: Biol. Crystallogr. 54 (1998)
905–921.
[34] J.P. Linge, S.I. O'Donoghue, M. Nilges, Automated assignment of ambiguous nuclear
overhauser effects with ARIA, Methods Enzymol. 339 (2001) 71–90.
[35] G.N. Ramachandran, C. Ramakrishnan, V. Sasisekharan, Stereochemistry of poly-
peptide chain conﬁgurations, J. Mol. Biol. 7 (1963) 95–99.
[36] R. Koradi, M. Billeter, K. Wuthrich, MOLMOL: a program for display and analysis
of macromolecular structures, J. Mol. Graph. 14 (1996) 51–55.
[37] R.A. Laskowski, J.A.C. Rullmann, M.W. MacArthur, R. Kaptein, J.M. Thornton, AQUA
and PROCHECK-NMR: Programs for checking the quality of protein structures
solved by NMR, J. Biomol. NMR 8 (1996) 477–486.
[38] L.T. Nguyen, D.J. Schibli, H.J. Vogel, Structural studies and model membrane inter-
actions of two peptides derived from bovine lactoferricin, J. Pept. Sci. 11 (2005)
379–389.
[39] B.N. Ames, E.F. Neufeld, V. Ginsberg, Assay of inorganic phosphate, total phos-
phate and phosphatases, Meth. Enzymol, Academic Press, New York, 1966,
pp. 115–118.
[40] N.P. Chongsiriwatana, A.E. Barron, Comparing bacterial membrane interactions of
antimicrobial peptides and their mimics, Methods Mol. Biol. 618 (2010) 171–182.
[41] M.H. Richmond, D.C. Clark, S. Wotton, Indirect method for assessing the
penetration of beta-lactamase-nonsusceptible penicillins and cephalosporins
in Escherichia coli strains, Antimicrob. Agents Chemother. 10 (1976) 215–218.
[42] M. Wu, E. Maier, R. Benz, R.E.W. Hancock, Mechanism of interaction of different
classes of cationic antimicrobial peptides with planar bilayers and with the
cytoplasmic membrane of Escherichia coli, Biochemistry 38 (1999) 7235–7242.
[43] C.B. Park, H.S. Kim, S.C. Kim, Mechanism of action of the antimicrobial peptide
buforin II: buforin II kills microorganisms by penetrating the cell membrane
and inhibiting cellular functions, Biochem. Biophys. Res. Commun. 244 (1998)
253–257.
[44] A. Patrzykat, C.L. Friedrich, L. Zhang, V. Mendoza, R.E.W. Hancock, Sublethal
concentrations of pleurocidin-derived antimicrobial peptides inhibit macromolecu-
lar synthesis in Escherichia coli, Antimicrob. Agents Chemother. 46 (2002) 605–614.
[45] T. Maniatis, Molecular Cloning: a Laboratory Manual, vol. 1st, Cold Spring
Harbour Laboratory, 1982, p. 68.
[46] K. Lohner, The role of membrane lipid composition in cell targeting of antimicro-
bial peptides, Development of Novel Antimicrobial Agents: Emerging Strategies,
Horizon Scientiﬁc Press, Norfolk, England, 2001, pp. 149–165.
[47] K.J. Hallock, D.K. Lee, A. Ramamoorthy, MSI-78, an analogue of the magainin an-
timicrobial peptides, disrupts lipid bilayer structure via positive curvature strain,
Biophys. J. 84 (2003) 3052–3060.
[48] P.E. Smith, J.R. Brender, A. Ramamoorthy, Induction of negative curvature as a
mechanism of cell toxicity by amyloidogenic peptides: the case of islet amyloid
polypeptide, J. Am. Chem. Soc. 131 (2009) 4470–4478.
[49] E.F. Haney, S. Nathoo, H.J. Vogel, E.J. Prenner, Induction of non-lamellar lipid
phases by antimicrobial peptides: a potential link to mode of action, Chem.
Phys. Lipids 163 (2010) 82–93.[50] I.B. Grishina, R.W. Woody, Contributions of tryptophan side chains to the circular
dichroism of globular proteins: exciton couplets and coupled oscillators, Faraday
Discuss. 99 (1994) 245–262.
[51] S.M. Kelly, T.J. Jess, N.C. Price, How to study proteins by circular dichroism,
Biochim. Biophys. Acta 1751 (2005) 119–139.
[52] D.I. Chan, E.J. Prenner, H.J. Vogel, Tryptophan- and arginine-rich antimicrobial
peptides: structures and mechanisms of action, Biochim. Biophys. Acta 1758
(2006) 1184–1202.
[53] S.S. Cohen, M. Sekiguchi, J.L. Stern, H.D. Barner, The synthesis of messenger RNA
without protein synthesis in normal and phage-infected thymineless strains of
Escherichia coli, Proc. Natl. Acad. Sci. U. S. A. 49 (1963) 699–707.
[54] A. Rozek, C.L. Friedrich, R.E.W. Hancock, Structure of the bovine antimicrobial
peptide indolicidin bound to dodecylphosphocholine and sodium dodecyl sulfate
micelles, Biochemistry 39 (2000) 15765–15774.
[55] L. Otvos Jr., Antibacterial peptides and proteins with multiple cellular targets,
J. Pept. Sci. 11 (2005) 697–706.
[56] J.D. Hale, R.E.W. Hancock, Alternative mechanisms of action of cationic antimicro-
bial peptides on bacteria, Expert Rev. Anti Infect. Ther. 5 (2007) 951–959.
[57] M. Cudic, L. Otvos Jr., Intracellular targets of antibacterial peptides, Curr. Drug
Targets 3 (2002) 101–106.
[58] J.P. Powers, M.M. Martin, D.L. Goosney, R.E.W. Hancock, The antimicrobial peptide
polyphemusin localizes to the cytoplasm of Escherichia coli following treatment,
Antimicrob. Agents Chemother. 50 (2006) 1522–1524.
[59] A.J. Rezansoff, H.N. Hunter, W. Jing, I.Y. Park, S.C. Kim, H.J. Vogel, Interactions of
the antimicrobial peptide Ac-FRWWHR-NH(2) with model membrane systems
and bacterial cells, J. Pept. Res. 65 (2005) 491–501.
[60] C.B. Park, M.S. Kim, S.C. Kim, Novel antimicrobial peptide from Bufo bufo
gargarizans, Biochem. Biophys. Res. Commun. 218 (1996) 408–413.
[61] S. Kobayashi, K. Takeshima, C.B. Park, S.C. Kim, K. Matsuzaki, Interactions of the
novel antimicrobial peptide buforin 2 with lipid bilayers: proline as a transloca-
tion promoting factor, Biochemistry 39 (2000) 8648–8654.
[62] C.H. Hsu, C. Chen, M.L. Jou, A.Y. Lee, Y.C. Lin, Y.P. Yu, W.T. Huang, S.H. Wu, Struc-
tural and DNA-binding studies on the bovine antimicrobial peptide, indolicidin:
evidence for multiple conformations involved in binding to membranes and
DNA, Nucleic Acids Res. 33 (2005) 4053–4064.
[63] S.C. Park, J.Y. Kim, C. Jeong, S. Yoo, K.S. Hahm, Y. Park, A plausible mode of action
of pseudin-2, an antimicrobial peptide from Pseudis paradoxa, Biochim. Biophys.
Acta 1808 (2011) 171–182.
[64] L.Y. Su, D.L. Willner, A.M. Segall, An antimicrobial peptide that targets DNA repair
intermediates in vitro inhibits Salmonella growth within murine macrophages,
Antimicrob. Agents Chemother. 54 (2010) 1888–1899.
[65] K. Hilpert, B. McLeod, J. Yu, M.R. Elliott, M. Rautenbach, S. Ruden, J. Burck, C.
Muhle-Goll, A.S. Ulrich, S. Keller, R.E.W. Hancock, Short cationic antimicrobial pep-
tides interact with ATP, Antimicrob. Agents Chemother. 54 (2010) 4480–4483.
[66] Y.H. Tu, Y.H. Ho, Y.C. Chuang, P.C. Chen, C.S. Chen, Identiﬁcation of lactoferricin B intra-
cellular targets using an Escherichia coli proteome chip, PLoS One 6 (2011) e28197.
[67] H. Ulvatne, O. Samuelsen, H.H. Haukland, M. Kramer, L.H. Vorland, Lactoferricin B
inhibits bacterial macromolecular synthesis in Escherichia coli and Bacillus subtilis,
FEMS Microbiol. Lett. 237 (2004) 377–384.
[68] C. Subbalakshmi, N. Sitaram, Mechanism of antimicrobial action of indolicidin,
FEMS Microbiol. Lett. 160 (1998) 91–96.
[69] A. Pellegrini, U. Thomas, P. Wild, E. Schraner, R. von Fellenberg, Effect of lysozyme
or modiﬁed lysozyme fragments on DNA and RNA synthesis and membrane per-
meability of Escherichia coli, Microbiol. Res. 155 (2000) 69–77.
[70] V.V. Andrushchenko, H.J. Vogel, E.J. Prenner, Interactions of tryptophan-rich
cathelicidin antimicrobial peptides with model membranes studied by differen-
tial scanning calorimetry, Biochim. Biophys. Acta 1768 (2007) 2447–2458.
[71] V.V. Andrushchenko, M.H. Aarabi, L.T. Nguyen, E.J. Prenner, H.J. Vogel, Thermo-
dynamics of the interactions of tryptophan-rich cathelicidin antimicrobial pep-
tides with model and natural membranes, Biochim. Biophys. Acta 1778 (2008)
1004–1014.
[72] D.J. Schibli, L.T. Nguyen, S.D. Kernaghan, O. Rekdal, H.J. Vogel, Structure–function
analysis of tritrpticin analogs: potential relationships between antimicrobial ac-
tivities, model membrane interactions, and their micelle-bound NMR structures,
Biophys. J. 91 (2006) 4413–4426.
[73] A.G. Vegh, K. Nagy, Z. Balint, A. Kerenyi, G. Rakhely, G. Varo, Z. Szegletes, Effect of
antimicrobial peptide-amide: indolicidin on biological membranes, J. Biomed.
Biotechnol. 2011 (2011) 670589.
[74] J.E. Shaw, J.R. Alattia, J.E. Verity, G.G. Prive, C.M. Yip, Mechanisms of antimicrobial
peptide action: studies of indolicidin assembly at model membrane interfaces by
in situ atomic force microscopy, J. Struct. Biol. 154 (2006) 42–58.
[75] J.C. Hsu, C.M. Yip, Molecular dynamics simulations of indolicidin association with
model lipid bilayers, Biophys. J. 92 (2007) L100–L102.
[76] J. Gesell,M. Zasloff, S.J. Opella, Two-dimensional H-1NMRexperiments show that the
23-residue magainin antibiotic peptide is an alpha-helix in dodecylphosphocholine
micelles, sodium dodecylsulfate micelles, and triﬂuoroethanol/water solution,
J. Biomol. NMR 9 (1997) 127–135.
[77] H.H. Haukland, H. Ulvatne, K. Sandvik, L.H. Vorland, The antimicrobial peptides
lactoferricin B and magainin 2 cross over the bacterial cytoplasmic membrane
and reside in the cytoplasm, FEBS Lett. 508 (2001) 389–393.
[78] Y. Lan, Y. Ye, J. Kozlowska, J.K. Lam, A.F. Drake, A.J. Mason, Structural contributions
to the intracellular targeting strategies of antimicrobial peptides, Biochim.
Biophys. Acta 1798 (2010) 1934–1943.
[79] E.T. Uyterhoeven, C.H. Butler, D. Ko, D.E. Elmore, Investigating the nucleic acid
interactions and antimicrobial mechanism of buforin II, FEBS Lett. 582 (2008)
1715–1718.
